MedTrace Logo

Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast Cancer

NCT00349011 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-08-30

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of a personalized menopausal therapy risk assessment and genetic counseling intervention on knowledge, risk perception, and decision-making in healthy women at increased risk for breast cancer.

Conditions

Interventions

PROCEDURE

Personalized risk assessment

PROCEDURE

genetic counseling intervention

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • Women and Infants Hospital of Rhode Island

    collaborator OTHER

  • Stony Brook University

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • Ellen T. Matloff, M.S. · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-08-31
Completion
2004-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00349011 on ClinicalTrials.gov